Plant regulatory elements and their uses

By designing and applying new gene regulatory elements, including promoters, leaders and introns, the difficulties in plant gene expression regulation are solved, effective control of plant specific traits and agronomic traits are achieved, and agronomic traits and characteristics of plants are improved. shape.

CN114807170BActive Publication Date: 2024-11-05MONSANTO TECHNOLOGY LLC
View PDF 30 Cites 0 Cited by

Patent Information

Application Number
CN202210523762.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2016-03-11
Filing Date
2017-03-08
Publication Date
2024-11-05
Estimated Expiration
2037-03-08

AI Technical Summary

Technical Problem

The prior art is difficult to effectively regulate plant gene expression, especially in the field of plant genetic engineering. There are shortcomings in the design and application of regulatory elements, which affects the realization of specific traits and agronomic traits of plants.

Method used

A novel gene regulatory element is provided, including a promoter, leader sequence, intron and 3' non-translated region, for regulating the expression of plant genes by operably linking with a heterologous transcribed DNA molecule, specific embodiments Recombinant DNA molecules, transgenic plant cells, plants and seeds are provided for achieving specific gene regulation in plants.

Benefits of technology

The fine regulation of plant gene expression is achieved, and specific gene activities can be regulated in plants, and the agronomic traits and characteristics of plants are improved, such as herbicide resistance and pest resistance, which enhances the ability to control agronomic traits.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003643159530000221
    Figure BDA0003643159530000221
  • Figure BDA0003643159530000231
    Figure BDA0003643159530000231
  • Figure BDA0003643159530000241
    Figure BDA0003643159530000241
Patent Text Reader

Abstract

The present invention provides recombinant DNA molecules and constructs for regulating gene expression in plants and their nucleotide sequences. The present invention also provides transgenic plants, plant cells, plant parts and seeds comprising recombinant DNA molecules operably linked to heterologous transcribable DNA molecules; and methods of using them.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the invention patent application with application date of March 8, 2017, application number 201780020170.8, and invention name “Plant regulatory elements and their uses”.

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS

[0003] This application claims the benefit of U.S. Provisional Application No. 62 / 306,790, filed March 11, 2016, which is incorporated by reference in its entirety.

[0004] Incorporation of Sequence Listing

[0005] The file named "MONS417WO-sequence_listing" contains 29.4KB (as Microsoft ), and created on March 6, 2017, is submitted electronically herewith and is incorporated herein by reference. Field of the Invention

[0006] The present invention relates to the field of plant molecular biology; and the field of plant genetic engineering. More specifically, the present invention relates to DNA molecules suitable for regulating gene expression in plants. Background Art

[0007] Regulatory elements are genetic elements that regulate gene activity by regulating the transcription of an operably linked transcribable DNA molecule. Such elements may include promoters, leader sequences, introns, and 3' untranslated regions, and are used in the fields of plant molecular biology and plant genetic engineering. Summary of the invention

[0008] The present invention provides novel gene regulatory elements for plants. The present invention also provides DNA constructs comprising regulatory elements. The present invention also provides transgenic plant cells, plants and seeds comprising regulatory elements. In one embodiment, the regulatory element is operably connected to a transcribable DNA molecule. In certain embodiments, the transcribable DNA molecule can be heterologous relative to the regulatory sequence. Therefore, in a specific embodiment, the regulatory element sequence provided by the present invention can be defined as being operably connected to a heterologous transcribable DNA molecule. The present invention also provides methods for preparing and using regulatory elements, DNA constructs comprising regulatory elements, and transgenic plant cells, plants and seeds comprising regulatory elements operably connected to transcribable DNA molecules.

[0009] Therefore, in one aspect, the present invention provides a recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: (a) a sequence having at least about 85% sequence identity to any one of SEQ ID NOs: 1-15; (b) a sequence comprising any one of SEQ ID NOs: 1-15; and (c) a fragment of any one of SEQ ID NOs: 1-15, wherein the fragment has gene regulatory activity; wherein the sequence is operably linked to a heterologous transcribable DNA molecule. "Heterologous transcribable DNA molecule" refers to a transcribable DNA molecule that is heterologous relative to the polynucleotide sequence to which it is operably linked. In a specific embodiment, the recombinant DNA molecule comprises a DNA sequence having at least about 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% sequence identity to the DNA sequence of any one of SEQ ID NOs: 1-15. In a specific embodiment, the DNA sequence comprises a regulatory element. In some embodiments, the regulatory element comprises a promoter. In other embodiments, the heterologous transcribable DNA molecule comprises a gene of agronomic interest, such as a gene that can provide herbicide resistance in plants, or a gene that can provide plant pest resistance in plants. In other embodiments, the invention provides a construct comprising a recombinant DNA molecule provided herein.

[0010] In another aspect, provided herein is a transgenic plant cell comprising a recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: (a) a sequence having at least about 85% sequence identity to any one of SEQ ID NOs: 1-15; (b) a sequence comprising any one of SEQ ID NOs: 1-15; and (c) a fragment of any one of SEQ ID NOs: 1-15, wherein the fragment has gene regulatory activity; wherein the DNA sequence is operably linked to a heterologous transcribable DNA molecule. In certain embodiments, the transgenic plant cell is a monocotyledonous plant cell. In other embodiments, the transgenic plant cell is a monocotyledonous plant cell or a dicotyledonous plant cell.

[0011] In yet another aspect, the present invention further provides a transgenic plant or part thereof, comprising a recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: a) a sequence having at least 85% sequence identity with any one of SEQ ID NO: 1-15; b) a sequence comprising any one of SEQ ID NO: 1-15; and c) a fragment of any one of SEQ ID NO: 1-15, wherein the fragment has gene regulatory activity; wherein the sequence is operably linked to a heterologous transcribable DNA molecule. In a specific embodiment, the transgenic plant is a progeny plant of any generation comprising the recombinant DNA molecule. The present invention also provides a transgenic seed comprising the recombinant DNA molecule, which produces such a transgenic plant when grown.

[0012] In another aspect, the present invention provides a method for producing a commodity product, comprising obtaining a transgenic plant or part thereof containing the recombinant DNA molecule of the present invention and producing a commodity product therefrom. In one embodiment, the commodity product is processed seeds, grains, plant parts, oils and meals.

[0013] In yet another aspect, the present invention provides a method for producing a transgenic plant comprising the recombinant DNA molecule of the present invention, the method comprising transforming a plant cell with the recombinant DNA molecule of the present invention to produce a transformed plant cell and regenerating a transgenic plant from the transformed plant cell.

[0014] Sequence Description

[0015] SEQ ID NO: 1 is the DNA sequence of a regulatory expression element set (EXP) comprising a promoter derived from the Cucumis melo putative ferredoxin 2 (Fe2) protein gene operably linked 5' to its native leader sequence.

[0016] SEQ ID NO: 2 is the promoter sequence derived from the melon putative ferredoxin 2 (Fe2) protein gene.

[0017] SEQ ID NO: 3 is the leader sequence derived from the melon putative ferredoxin 2 (Fe2) protein gene.

[0018] SEQ ID NO: 4 is the DNA sequence of EXP comprising the promoter derived from the melon chlorophyll ab binding protein 13 gene operably linked 5' to its native leader sequence.

[0019] SEQ ID NO: 5 is the promoter sequence derived from the melon chlorophyll ab binding protein 13 gene.

[0020] SEQ ID NO: 6 is the leader sequence derived from the melon chlorophyll ab binding protein 13 gene.

[0021] SEQ ID NO: 7 is the DNA sequence of EXP, which comprises the promoter derived from the Melon B-box zinc finger protein 24-like gene operably linked 5' to its native leader sequence.

[0022] SEQ ID NO: 8 is the promoter sequence derived from the melon B-box zinc finger protein 24-like gene.

[0023] SEQ ID NO: 9 is the leader sequence derived from the melon B-box zinc finger protein 24-like gene.

[0024] SEQ ID NO: 10 is the DNA sequence of EXP, which comprises the promoter derived from the Medicago truncatula light-harvesting complex protein b2 gene operably linked 5' to its native leader sequence.

[0025] SEQ ID NO: 11 is the promoter sequence of the Medicago truncatula light-harvesting complex protein b2 gene.

[0026] SEQ ID NO: 12 is the leader sequence derived from the Medicago truncatula light-harvesting complex protein b2 gene.

[0027] SEQ ID NO: 13 is the DNA sequence of EXP, which comprises the promoter derived from the Medicago truncatula photosystem II chloroplast precursor gene operably linked 5' to its native leader sequence.

[0028] SEQ ID NO: 14 is the promoter sequence derived from the Medicago truncatula photosystem II chloroplast precursor gene.

[0029] SEQ ID NO: 15 is the leader sequence promoter sequence derived from the Medicago truncatula photosystem II chloroplast precursor gene.

[0030] SEQ ID NO: 16 is the enhancer sequence derived from the promoter of the Medicago truncatula light-harvesting complex protein b2 gene.

[0031] SEQ ID NO: 17 is the coding sequence of β-glucuronidase (GUS) with a processable intron.

[0032] SEQ ID NO: 18 is the 3'UTR sequence derived from the E6 gene of Gossypium barbadense. DETAILED DESCRIPTION

[0033] The present invention provides DNA molecules with gene regulatory activity in plants. The nucleotide sequences of these DNA molecules are provided as SEQ ID NO: 1-15. These DNA molecules can affect the expression of operably linked transcribable DNA molecules in plant tissues, and thus regulate the gene expression of operably linked transgenics in transgenic plants. The present invention also provides methods for modifying, producing and using them. The present invention also provides compositions comprising transgenic plant cells, plants, plant parts and seeds containing the recombinant DNA molecules of the present invention, as well as methods for preparing and using them.

[0034] The following definitions and methods are provided to better define the present invention and guide those skilled in the art to practice the present invention. Unless otherwise indicated, terms should be understood according to conventional usage by those skilled in the relevant art.

[0035] DNA molecules

[0036] As used herein, the term "DNA" or "DNA molecule" refers to a double-stranded DNA molecule of genomic or synthetic origin, i.e., a polymer of deoxyribonucleotide bases or DNA molecules, read from the 5' (upstream) end to the 3' (downstream) end. As used herein, the term "DNA sequence" refers to the nucleotide sequence of a DNA molecule. The nomenclature used herein is the nomenclature required by Article 37 of §1.822 of the United States Code of Federal Regulations, and is described in Tables 1 and 3 of Appendix 2 of WIPO Standard ST.25 (1998).

[0037] As used herein, a "recombinant DNA molecule" is a DNA molecule comprising a combination of DNA molecules that would not naturally exist without human intervention. For example, a recombinant DNA molecule can be a DNA molecule composed of at least two DNA molecules that are heterologous to each other, a DNA molecule comprising a DNA sequence that deviates from a DNA sequence that exists in nature, or a DNA molecule that is integrated into the DNA of a host cell by genetic transformation or gene editing.

[0038] As used herein, the term "sequence identity" refers to the degree to which two optimally aligned polynucleotide sequences or two optimally aligned polypeptide sequences are identical. An optimal sequence alignment is created by manually aligning two sequences (e.g., a reference sequence with another sequence) to maximize the number of nucleotide matches in the sequence alignment with appropriate internal nucleotide insertions, deletions, or gaps. As used herein, the term "reference sequence" refers to a DNA sequence provided for a DNA sequence such as that provided in SEQ ID NOs: 1-15.

[0039] As used herein, the term "percent sequence identity" or "percent identity" or "% identity" is the identity score multiplied by 100. The "identity score" for a sequence optimally aligned to a reference sequence is the number of nucleotide matches in the optimal alignment divided by the total number of nucleotides in the reference sequence, e.g., the total number of nucleotides over the entire length of the reference sequence. Thus, one embodiment of the present invention provides a DNA molecule comprising a sequence that, when optimally aligned with a reference sequence provided herein as SEQ ID NOs: 1-15, has at least about 85% identity, at least about 86% identity, at least about 87% identity, at least about 88% identity, at least about 89% identity, at least about 90% identity, at least about 91% identity, at least about 92% identity, at least about 93% identity, at least about 94% identity, at least about 95% identity, at least about 96% identity, at least about 97% identity, at least about 98% identity, at least about 99% identity, or at least about 100% identity to the reference sequence.

[0040] Regulatory elements

[0041] Regulatory elements such as promoters, leader sequences (also known as 5'UTRs), enhancers, introns, and transcription termination regions (or 3'UTRs) play an integral role in the overall expression of genes in living cells. As used herein, the term "regulatory element" refers to a DNA molecule with gene regulatory activity. As used herein, the term "gene regulatory activity" refers to the ability to affect the expression of an operably linked transcribable DNA molecule, for example, by affecting the transcription and / or translation of the operably linked transcribable DNA molecule. Regulatory elements that function in plants, such as promoters, leader sequences, enhancers, introns, and 3'UTRs are therefore suitable for modifying plant phenotypes via genetic engineering.

[0042] As used herein, "regulatory expression element group" or "EXP" sequence can refer to a group of operably linked regulatory elements, such as enhancers, promoters, leader sequences and introns. Thus, the regulatory expression element group can include, for example, a promoter operably linked to the leader sequence 5'. EXPs that can be used to implement the present invention include 1, 4, 7, 10 and 13.

[0043] Regulatory elements can be characterized as their gene expression patterns, for example, positive and / or negative effects, such as constitutive expression or time, space, development, organization, environment, physiology, pathology, cell cycle and / or chemical responsiveness expression and any combination thereof, and are also characterized as quantitative or qualitative indications. As used herein, "gene expression pattern" is any pattern of transcribed RNA molecules that are operably connected DNA molecules. The transcribed RNA molecules can be translated to produce protein molecules or can provide antisense or other regulatory RNA molecules, such as double-stranded RNA (dsRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), microRNA (miRNA) etc.

[0044] As used herein, the term "protein expression" is any pattern of translation of transcribed RNA molecules into protein molecules. Protein expression can be characterized by its temporal, spatial, developmental or morphological characteristics and quantitative or qualitative indications.

[0045] Promoters are used as regulatory elements for regulating the expression of operably linked transcribable DNA molecules. As used herein, the term "promoter" generally refers to a DNA molecule that participates in the recognition and binding of RNA polymerase II and other proteins (such as trans-acting transcription factors) to initiate transcription. Initially, the promoter can be isolated from the 5' untranslated region (5'UTR) of the genomic copy of the gene. Alternatively, the promoter can be a synthetically produced or manipulated DNA molecule. The promoter can also be chimeric. A chimeric promoter is produced by the fusion of two or more heterologous DNA molecules. Promoters for implementing the present invention include promoter elements, or fragments or variants thereof, contained in any one of SEQ ID NO:2, 5, 8, 11 and 14. In a specific embodiment of the present invention, the claimed DNA molecule and any variant or derivative thereof as described herein are further defined as comprising promoter activity, i.e., being able to act as a promoter in a host cell (such as in a transgenic plant). In further specific embodiments, fragments may be defined as exhibiting the promoter activity possessed by the original promoter molecule from which they are derived, or fragments may contain a "minimal promoter" that provides basal transcription levels and is composed of a TATA box, other known transcription factor binding site motifs, or equivalent DNA sequences for recognizing and binding the RNA polymerase II complex to initiate transcription.

[0046] In one embodiment, a fragment of a promoter sequence disclosed herein is provided. As described above, a promoter fragment may contain promoter activity and may be used alone or in combination with other promoters and promoter fragments, for example, to construct a chimeric promoter, or in combination with other EXP and EXP fragments. In a specific embodiment, a fragment of a promoter is provided, which comprises at least about 50, at least about 75, at least about 95, at least about 100, at least about 125, at least about 150, at least about 175, at least about 200, at least about 225, at least about 250, at least about 275, at least about 300, at least about 500, at least about 600, at least about 700, at least about 750, at least about 800, at least about 900 or at least about 1000 consecutive nucleotides or longer DNA molecules having promoter activity disclosed herein. In certain embodiments, the present invention provides a fragment of any one of SEQ ID NOs: 1-15, which has full-length sequence activity. Methods for generating such fragments from starting promoter molecules are well known in the art.

[0047] Compositions derived from any promoter element contained within any one of SEQ ID NOs: 2, 5, 8, 11, and 14 (such as internal or 5' deletions) can be generated, for example, using methods known in the art to improve or alter expression, including by removing elements that have a positive or negative effect on expression; duplicating elements that have a positive or negative effect on expression; and / or duplicating or removing elements that have a tissue or cell-specific effect on expression. Compositions derived from any promoter element contained within any one of SEQ ID NOs: 2, 5, 8, 11, and 14 and including 3' deletions can be used, for example, to make enhancer elements in which the TATA box element or its equivalent and downstream sequences are removed. Other deletions can be made to remove any element that has a positive or negative; tissue-specific; cell-specific; or time-specific (such as but not limited to circadian) effect on expression. Any promoter element contained within any one of SEQ ID NOs: 2, 5, 8, 11, and 14 and fragments or enhancers derived therefrom can be used to prepare chimeric transcriptional regulatory element compositions.

[0048] According to the present invention, the presence of known promoter elements, i.e., DNA sequence features, such as the TATA box and other known transcription factor binding site motifs, can be analyzed in a promoter or promoter fragment. Those skilled in the art can use the identification of these known promoter elements to design variants of promoters with expression patterns similar to the original promoter.

[0049] As used herein, the term "leader sequence" refers to a DNA molecule separated from the non-translated 5' region (5'UTR) of a gene, and is generally defined as a nucleotide segment between a transcription start site (TSS) and a protein coding sequence start site. Alternatively, a leader sequence can be a synthetically produced or manipulated DNA element. The leader sequence can be used as a 5' regulatory element for regulating the expression of an operably linked transcribable DNA molecule. The leader molecule can be used with a heterologous promoter or its natural promoter. The leader sequence for implementing the present invention includes any leader element or a fragment or variant contained in SEQ ID NO:3, 6, 9, 12 and 15 or any SEQ ID NO:1, 4, 7, 10 and 13. In a specific embodiment, such DNA sequence can be defined as a leader sequence that can serve as a host cell (including, for example, a transgenic plant cell). In one embodiment, such a sequence is decoded as comprising a leader sequence activity.

[0050] The leader sequences represented by SEQ ID NOs: 3, 6, 9, 12 and 15 (also referred to as 5'UTR) or any leader element contained within any one of SEQ ID NOs: 1, 4, 7, 10 and 13 may consist of a regulatory element or may adopt a secondary structure that may have an effect on the transcription or translation of an operably linked transcribable DNA molecule. The leader sequences represented by SEQ ID NOs: 3, 6, 9, 12 and 15 or any leader element contained within any one of SEQ ID NOs: 1, 4, 7, 10 and 13 may be used in accordance with the present invention to prepare chimeric regulatory elements that affect the transcription or translation of an operably linked transcribable DNA molecule.

[0051] As used herein, the term "intron" refers to a DNA molecule that can be isolated or identified from a gene and can generally be defined as a region that is sheared off during the processing of the messenger RNA (mRNA) before translation. Alternatively, an intron can be a synthetically produced or manipulated DNA element. An intron can contain an enhancer element that affects the transcription of an operably linked gene. An intron can be used as a regulatory element for regulating the expression of an operably linked transcribable DNA molecule. A construct can include an intron, and the intron may or may not be heterologous relative to the transcribable DNA molecule. Examples of introns in this area include rice actin introns and corn HSP70 introns.

[0052] In plants, relative to constructs lacking introns, the inclusion of some introns in gene constructs leads to an increase in mRNA and protein accumulation. This effect is referred to as "intron-mediated enhancement" (IME) of gene expression. Introns known to stimulate expression in plants have been identified in the following: corn genes (e.g., tubA1, Adh1, Sh1, and Ubil), rice genes (e.g., tpi), and dicot genes, such as those from petunia (e.g., rbcS), potato (e.g., st-ls1), and from Arabidopsis thaliana (e.g., ubq3 and pat1). Deletions or mutations in the splicing sites of introns have been shown to reduce gene expression, indicating that splicing may be required for IME. However, IME in dicots has been shown by point mutations in the splicing sites of the pat1 gene from Arabidopsis thaliana. Using the same intron multiple times in a plant has shown disadvantages. In those cases, it is necessary to have a collection of basic control elements for constructing suitable recombinant DNA elements.

[0053] As used herein, the term "3' transcription termination molecule", "3' untranslated region" or "3'UTR" refers to a DNA molecule used during transcription into the untranslated region of the 3' portion of an mRNA molecule. The 3' untranslated region of an mRNA molecule can be produced by specific cleavage and 3' polyadenylation (also known as a polyA tail). The 3'UTR can be operably linked to and located downstream of a transcribable DNA molecule, and can include a polyadenylation signal and other regulatory signals that can affect transcription, mRNA processing or gene expression. The polyA tail is believed to play a role in mRNA stability and translation initiation. Examples of 3' transcription termination molecules in the art are the nopaline synthase 3' region; the wheat hsp17 3' region, the pea rubisco small subunit 3' region, the cotton E6 3' region, and the coix seed alcohol-soluble protein 3'UTR.

[0054] It is usually found that 3'UTR has beneficial uses for the recombinant expression of specific DNA molecules. Weak 3'UTR has the potential to produce read-through, which can affect the expression of DNA molecules located in adjacent expression cassettes. Appropriate control of transcription termination can prevent the DNA sequence (such as other expression cassettes) that is read-through, and can further allow effective recycling of RNA polymerase to improve gene expression. Effective termination of transcription (releasing RNA polymerase II from DNA) is a prerequisite for restarting transcription, thereby directly affecting the overall transcription level. After transcription termination, mature mRNA is released from the synthesis site, and the template is transported to the cytoplasm. Eukaryotic mRNA accumulates in vivo in the form of poly (A), making it difficult to detect transcription termination sites by conventional methods. However, it is difficult to predict functional and effective 3'UTR by bioinformatics methods because there is no conservative DNA sequence that can easily predict effective 3'UTR.

[0055] From a practical standpoint, it is often beneficial for the 3'UTR used in the expression cassette to have the following characteristics. The 3'UTR should be able to effectively and efficiently terminate transcription of the transgene and prevent transcripts from reading through into any adjacent DNA sequences (such as those that may be comprised of another expression cassette in the case where multiple expression cassettes reside in one transfer DNA (T-DNA)) or adjacent chromosomal DNA into which the T-DNA has been inserted. The 3'UTR should not result in a reduction in the transcriptional activity conferred by the promoter, leader sequence, enhancers, and introns used to drive expression of the DNA molecule. In plant biotechnology, the 3'UTR is often used to initiate amplification reactions of reverse transcribed RNA extracted from transformed plants and is used to: (1) assess the transcriptional activity or expression of the expression cassette once integrated into the plant chromosome; (2) assess the number of copies of the insert in the plant DNA; and (3) assess the zygosity of the resulting seeds after propagation. The 3'UTR is also used in amplification reactions of DNA extracted from transformed plants to characterize the integrity of the inserted cassette.

[0056] As used herein, the term "enhancer" or "enhancer element" refers to a cis-acting regulatory element, also known as a cis-element, which confers an aspect of the overall expression pattern, but is generally insufficient to drive the transcription of an operably linked transcribable DNA molecule alone. Unlike a promoter, an enhancer element generally does not include a transcription start site (TSS) or a TATA box or an equivalent DNA sequence. A promoter or promoter fragment may naturally contain one or more enhancer elements that affect the transcription of an operably linked DNA sequence. An enhancer element may also be fused to a promoter to produce a chimeric promoter cis-element, which confers an aspect of the overall regulation of gene expression. An example of an enhancer element derived from the promoter of the Medicago truncatula light-harvesting complex protein b2 precursor gene is provided as SEQ ID NO:16.

[0057] Many promoter enhancer elements are thought to bind DNA binding proteins and / or affect DNA topology, thereby producing local conformations that selectively allow or restrict RNA polymerase to enter the DNA template or promote the selective opening of the double helix at the transcription start site. Enhancer elements can play a role in binding transcription factors that regulate transcription. Some enhancer elements bind more than one transcription factor, and transcription factors can interact with more than one enhancer domain with different affinities. Enhancer elements can be identified by the following numerous techniques, including deletion analysis, i.e., one or more nucleotides are deleted from the 5' end or inside the promoter; DNA binding protein analysis performed using DNA enzyme I footprinting, methylation interference, electrophoretic mobility shift analysis, in vivo genomic footprinting by ligation-mediated polymerase chain reaction (PCR) and other conventional assays; or by using conventional DNA sequence comparison methods such as BLAST, using known cis-element motifs or enhancer elements as target sequences or target motifs for DNA sequence similarity analysis. The fine structure of the enhancer domain can be further studied by mutagenesis (or substitution) of one or more nucleotides or by other conventional methods known in the art. Enhancer elements can be obtained by chemical synthesis or by isolation from regulatory elements comprising these elements, and they can be synthesized with additional flanking nucleotides containing useful restriction enzyme sites to facilitate subsequence manipulation. Thus, the present invention encompasses the design, construction, and use of enhancer elements for regulating expression of operably linked transcribable DNA molecules according to the methods disclosed herein.

[0058] As used herein, the term "chimeric" refers to a single DNA molecule produced by fusing a first DNA molecule to a second DNA molecule, wherein neither the first DNA molecule nor the second DNA molecule is usually found in this configuration (i.e., fused to each other). Therefore, a chimeric DNA molecule is a new DNA molecule that is not usually found in nature under other circumstances. As used herein, the term "chimeric promoter" refers to a promoter produced by such manipulation of a DNA molecule. A chimeric promoter can combine two or more DNA fragments; for example, a fusion of a promoter with an enhancer element. Therefore, the present invention encompasses the design, construction, and use of chimeric promoters for regulating the expression of operably linked transcribable DNA molecules according to the methods disclosed herein.

[0059] Chimeric regulatory elements can be designed to include various constituent elements, which can be operably connected by various methods known in the art, such as restriction enzyme digestion and connection, connection of independent clones, modular assembly of PCR products during amplification, or direct chemical synthesis of regulatory elements, as well as other methods known in the art. The various chimeric regulatory elements obtained can be composed of the same constituent elements or the same constituent elements but different variants in the DNA sequence or the DNA sequence containing the connecting DNA sequence or the sequence allowing the components to be operably connected. In the present invention, the DNA sequence provided as SEQ ID NO: 1-15 can provide a regulatory element reference sequence, wherein the constituent elements containing the reference sequence can be connected by methods known in the art, and can include substitutions, deletions and / or insertions of one or more nucleotides or mutations naturally occurring in bacterial and plant cell transformation.

[0060] As used herein, the term "variant" refers to a second DNA molecule, such as a regulatory element, which is similar but not identical to the first DNA molecule in composition, and wherein the second DNA molecule still maintains a general function, i.e., the same or similar expression pattern of the first DNA molecule, for example, by more or less equivalent transcriptional activity. The variant can be a shorter or truncated form of the first DNA molecule and / or an altered form of the first DNA molecule sequence, such as a variant with different restriction enzyme sites and / or internal deletions, substitutions and / or insertions. "Variant" can also encompass a regulatory element having a nucleotide sequence, the nucleotide sequence comprising substitutions, deletions and / or insertions of one or more nucleotides of a reference sequence, wherein the derived regulatory element has a more or less equivalent transcriptional or translational activity compared to the corresponding parent regulatory molecule. The regulatory element "variant" also encompasses variants produced by naturally occurring mutations in bacterial and plant cell transformation. In the present invention, the polynucleotide sequence provided as SEQ ID NO: 1-15 can be used to produce a variant similar but not identical to the DNA sequence of the original regulatory element in composition, while still maintaining general function, i.e., the same or similar expression pattern of the original regulatory element. The generation of such variations of the present invention is well within the skill of one of ordinary skill in the art in light of the present disclosure and are encompassed within the scope of the present invention.

[0061] In the present application, reference to "isolated DNA molecules" or equivalent terms or phrases is intended to mean that the DNA molecules are present alone or in combination with other compositions, but not in their natural environment. For example, nucleic acid elements naturally found in the DNA of the genome of an organism, such as coding sequences, intron sequences, non-translated leader sequences, promoter sequences, transcription termination sequences, etc., are not considered to be "isolated", as long as the elements are located in the genome of the organism and at the position in the genome where they are naturally found. However, each of these elements and sub-portions of these elements will be "isolated" within the scope of the present disclosure, as long as the elements are not in the genome of the organism and at the position in the genome where they are naturally found. For the purposes of the present disclosure, any transgenic nucleotide sequence, that is, a nucleotide sequence of a DNA inserted into the genome of a plant or bacterial cell or present in an extrachromosomal vector, will be considered to be an isolated nucleotide sequence, whether or not the sequence is present in a plasmid or similar structure used to transform a cell, in the genome of a plant or bacterium, or in a detectable amount in a tissue, progeny, biological sample, or commercial product derived from the plant or bacterium.

[0062] The efficacy of the modifications, duplications or deletions described herein on the desired expression of a particular transgene can be tested empirically in stable and transient plant assays, such as those described in the working examples herein, to validate the results, which may vary depending on the changes made and the goals of the starting DNA molecule changes.

[0063] Construct

[0064] As used herein, the term "construct" means any recombinant DNA molecule derived from any source, such as a plasmid, a cosmid, a virus, a phage, or a linear or circular DNA or RNA molecule, which is capable of genomic integration or autonomous replication, comprising a DNA molecule, wherein at least one DNA molecule has been connected to another DNA molecule in a functionally operable manner (i.e., operably linked). As used herein, the term "vector" means any construct that can be used for transformation purposes, i.e., introducing heterologous DNA or RNA into a host cell. Constructs typically include one or more expression cassettes. As used herein, "expression cassette" refers to a DNA molecule comprising at least one transcribable DNA molecule, which is operably linked to one or more regulatory elements, typically at least one promoter and 3'UTR.

[0065] As used herein, the term "operably connected" refers to that a first DNA molecule is connected to a second DNA molecule, wherein the first and second DNA molecules are arranged so that the first DNA molecule affects the function of the second DNA molecule. Two DNA molecules may or may not be part of a single continuous DNA molecule, and may be adjacent or non-adjacent. For example, if a promoter regulates the transcription of a transcribable DNA molecule of interest in a cell, the promoter is operably connected to the transcribable DNA molecule. For example, a leader sequence may be operably connected to a DNA sequence when it is able to affect the transcription or translation of the DNA sequence.

[0066] In one embodiment, the construct of the present invention can be provided as a double tumor-inducing (Ti) plasmid border construct having the right border (RB or AGRtu.RB) and left border (LB or AGRtu.LB) regions of the Ti plasmid isolated from Agrobacterium tumefaciens, wherein the Ti plasmid contains T-DNA and transfer molecules provided by Agrobacterium tumefaciens cells, thereby allowing T-DNA to be integrated into the genome of plant cells (see, e.g., U.S. Pat. No. 6,603,061). The construct may also contain a plasmid backbone DNA fragment that provides replication function and antibiotic selection in bacterial cells, e.g., an E. coli replication origin such as ori322, a broad host range replication origin such as oriV or oriRi, and a coding region for a selectable marker, such as Spec / Strp encoding Tn7 aminoglycoside adenylyltransferase (aadA), which confers resistance to spectinomycin or streptomycin or gentamicin (Gm, Gent) selectable marker genes. For plant transformation, the host bacterial strain is typically Agrobacterium tumefaciens ABI, C58, or LBA4404; however, other strains known to those skilled in the art of plant transformation may also function in the present invention.

[0067] Methods for assembling and introducing constructs into cells in such a manner that transcribable DNA molecules are transcribed into functional mRNA molecules (which are translated and expressed as proteins) are known in the art. For the practice of the present invention, conventional compositions and methods for preparing and using constructs and host cells are well known to those skilled in the art. Typical vectors suitable for expressing nucleic acids in higher plants are well known in the art and include vectors derived from the Ti plasmid of Agrobacterium tumefaciens and the pCaMVCN transfer control vector.

[0068] Various regulatory elements may be included in the construct, including any construct provided herein. Any such regulatory element may be provided in combination with other regulatory elements. This combination may be designed or modified to produce desired regulatory features. In one embodiment, construct of the present invention comprises at least one regulatory element operably connected to a transcribable DNA molecule, which is operably connected to a 3'UTR.

[0069] The constructs of the present invention may include any promoter or leader sequence provided herein or known in the art. For example, the promoter of the present invention may be operably linked to a heterologous non-translated 5' leader sequence (e.g., a leader sequence derived from a heat shock protein gene). Alternatively, the leader sequence of the present invention may be operably linked to a heterologous promoter (e.g., a cauliflower mosaic virus 35S transcriptional promoter).

[0070] The expression cassette may also include a transit peptide coding sequence encoding a peptide suitable for operably linked protein pairs, particularly the following subcellular targeting: chloroplasts, leucoplasts, or other plastid organelles; mitochondria; peroxisomes; vacuoles; or extracellular locations. Many chloroplast-localized proteins are expressed as precursors from nuclear genes and targeted to chloroplasts by chloroplast transit peptides (CTPs). Examples of such isolated chloroplast proteins include, but are not limited to, those proteins associated with ribulose-1,5,-bisphosphate carboxylase small subunit (SSU), ferredoxin, ferredoxin oxidoreductase, light-harvesting complex protein I and protein II, thioredoxin F, and enolpyruvate shikimate phosphate synthase (EPSPS). Chloroplast transit peptides are described, for example, in U.S. Patent No. 7,193,133. It has been demonstrated that non-chloroplast proteins can be targeted to chloroplasts by expressing heterologous CTPs operably linked to transgenes encoding non-chloroplast proteins.

[0071] Transcriptable DNA molecule

[0072] As used herein, the term "transcribable DNA molecule" refers to any DNA molecule that can be transcribed into an RNA molecule, including but not limited to those with protein coding sequences and those that produce RNA molecules with sequences suitable for gene suppression. The type of DNA molecule may include but is not limited to a DNA molecule from the same plant, a DNA molecule from another plant, a DNA molecule from a different organism, or a synthetic DNA molecule, such as a DNA molecule containing the antisense information of a gene, or a DNA molecule encoding a genetically modified form of an artificial, synthetic or other modified form. Exemplary transcribable DNA molecules for incorporation into the construct of the present invention include, for example, DNA molecules or genes from species other than the species into which the DNA molecule is incorporated, or genes derived from the same species or present in the same species but incorporated into recipient cells by genetic engineering methods rather than classical breeding techniques.

[0073] "Transgene" refers to a transcribable DNA molecule that is heterologous to a host cell, at least with respect to its location in the host cell genome and / or that has been artificially incorporated into the genome of a host cell, either in the present or any previous cell.

[0074] A regulatory element such as a promoter of the present invention can be operably connected to a transcribable DNA molecule, which is heterologous to the regulatory element. As used herein, the term "heterologous" refers to a combination of two or more DNA molecules, wherein such a combination is not usually found in nature. For example, two DNA molecules can be derived from different species and / or two DNA molecules can be derived from different genes, for example, different genes from the same species or the same gene from different species. A regulatory element is therefore heterologous to an operably connected transcribable DNA molecule, if such a combination is not usually found in nature, that is, a transcribable DNA molecule is not usually present in nature in a form operably connected to a regulatory element.

[0075] The transcribable DNA molecule can generally be any DNA molecule that needs transcript expression. This expression of transcript may lead to the translation of the resulting mRNA molecule, and thus cause protein expression. Or, for example, a transcribable DNA molecule can be designed to eventually reduce the expression of a specific gene or protein. In one embodiment, this can be achieved by using a transcribable DNA molecule oriented in an antisense direction. Those of ordinary skill in the art are familiar with using this antisense technology. Any gene can be negatively regulated in this way, and in one embodiment, a transcribable DNA molecule can be designed to suppress a specific gene by the expression of a dsRNA, siRNA or miRNA molecule.

[0076] Thus, one embodiment of the present invention is a recombinant DNA molecule comprising a regulatory element of the present invention, such as those provided as SEQ ID NOs: 1-15, operably linked to a heterologous transcribable DNA molecule so that when the construct is integrated into the genome of a transgenic plant cell, the transcription of the transcribable DNA molecule is regulated at a desired level or in a desired pattern. In one embodiment, the transcribable DNA molecule comprises a protein coding region of a gene, and in another embodiment, the transcribable DNA molecule comprises an antisense region of a gene.

[0077] Genes of interest in agronomy

[0078] The transcribable DNA molecule can be the gene that pays close attention to agronomy.As used herein, the term "gene that pays close attention to agronomy" refers to the transcribable DNA molecule that gives the desired characteristics when expressed in specific plant tissues, cells or cell types.The product of the gene that pays close attention to agronomy can work in plants, so that plant morphology, physiology, growth, development, yield, grain composition, nutritional characteristics, disease or pest resistance and / or environment or chemical tolerance are affected, or can serve as pesticides in the food of insects that feed on plants.In one embodiment of the invention, the regulatory element of the present invention is incorporated into the construct so that the regulatory element is operably connected to the transcribable DNA molecule, and the transcribable DNA molecule is the gene that pays close attention to agronomy.In the transgenic plant containing this construct, the expression of the gene that pays close attention to agronomy can give useful agronomy traits. Beneficial agronomic traits may include, for example, but are not limited to, herbicide tolerance, insect control, improved yield, disease resistance, pathogen resistance, improved plant growth and development, improved starch content, improved oil content, improved fatty acid content, improved protein content, improved fruit ripening, enhanced animal and human nutrition, biopolymer production, tolerance to environmental stress, pharmaceutical peptides, improved processing quality, improved flavor, hybrid seed production utility, improved fiber production, and desirable biofuel production.

[0079] Examples of genes of agronomic interest known in the art include those for: herbicide resistance (U.S. Pat. Nos. 6,803,501; 6,448,476; 6,248,876; 6,225,114; 6,107,549; 5,866,775; 5,804,425; 5,633,435; and 5,463,175); yield enhancement (U.S. Pat. Nos. USRE38,446; 6,716,474; 6,663,906; 6,476,295; 6,441,277; 6,423,828; 6,399,330; 6,372,211; 6,235,971; 6,222,098; and 5,71 6,837); insect control (U.S. Patent Nos. 6,809,078; 6,713,063; 6,686,452; 6,657,046; 6,645,497; 6,642,030; 6,639,054; 6,620,988; 6,593,293; 6,555,655; 6,538,109; 6,537,756; 6,521,442; 6,501,009; 6,468,523; 6,326,351; 6,313,378; 6,284,949; 6,281,016; 6,248,536; 6,242,241; 6,221,649; 6,177,615; 6, 156,573; 6,153,814; 6,110,464; 6,093,695; 6,063,756; 6,063,597; 6,023,013; 5,959,091; 5,942,664; 5,942,658,5,880,275; 5,763,245; and 5,763,241); fungal resistance (U.S. Pat. Nos. 6,653,280; 6,573,361; 6,506,962; 6,316,407; 6,215,048; 5,516,671; 5,773,696; 6,121,436; 6,316,407; and 6,506,962); viral resistance ( Nos. 6,617,496; 6,608,241; 6,015,940; 6,013,864; 5,850,023; and 5,304,730); nematode resistance (U.S. Pat. No. 6,228,992); bacterial disease resistance (U.S. Pat. No. 5,516,671); plant growth and development (U.S. Pat. Nos. 6,723,897 and 6,518,488); starch production (U.S. Pat. Nos. 6,538,181; 6,538,179; 6,538,178; 5,750,876; 6,476,295); improved oil production (U.S. Pat. Nos. 6,444,876; 6,426,447; and 6,380,462);High oil yield (U.S. Pat. Nos. 6,495,739; 5,608,149; 6,483,008; and 6,476,295); improved fatty acid content (U.S. Pat. Nos. 6,828,475; 6,822,141; 6,770,465; 6,706,950; 6,660,849; 6,596,538; 6,589,767; 6,537,750; 6,489,461; and 6,4 59,018); high protein yield (U.S. Pat. No. 6,380,466); fruit ripening (U.S. Pat. No. 5,512,466); enhanced animal and human nutrition (U.S. Pat. Nos. 6,723,837; 6,653,530; 6,5412,59; 5,985,605; and 6,171,640); biopolymers (U.S. Pat. Nos. USRE37,543; 6,228,623; and 5,958,74 5 and 6,946,588); environmental stress resistance (U.S. Patent No. 6,072,103); pharmaceutical peptides and secretable peptides (U.S. Patent Nos. 6,812,379; 6,774,283; 6,140,075; and 6,080,560); improved processing properties (U.S. Patent No. 6,476,295); improved digestibility (U.S. Patent No. 6,531,648); low raffinose (U.S. Patent No. 6,166,292); industrial Enzyme production (U.S. Pat. No. 5,543,576); improved flavor (U.S. Pat. No. 6,011,199); nitrogen fixation (U.S. Pat. No. 5,229,114); hybrid seed production (U.S. Pat. No. 5,689,041); fiber production (U.S. Pat. Nos. 6,576,818; 6,271,443; 5,981,834; and 5,869,720); and biofuel production (U.S. Pat. No. 5,998,700).

[0080] Alternatively, the gene of interest in agronomy can affect the above-mentioned plant characteristics or phenotypes by encoding RNA molecules, which, for example, achieve targeted regulation of gene expression of endogenous genes by: antisense (see, e.g., U.S. Patent No. 5,107,065); inhibitory RNA ("RNAi", including regulation of gene expression by miRNA-, siRNA-, trans-acting siRNA- and stage sRNA-mediated mechanisms, e.g., as described in published applications US2006 / 0200878 and US2008 / 0066206 and U.S. Patent Application No. 11 / 974,469); or co-suppression-mediated mechanisms. The RNA can also be a catalytic RNA molecule (e.g., a ribozyme or riboswitch; see, e.g., US2006 / 0200878) that is engineered to cut the desired endogenous mRNA product. Methods for constructing a construct in a certain manner and introducing it into a cell so that a transcribable DNA molecule is transcribed into a molecule capable of causing gene inhibition are known in the art.

[0081] Selectable markers

[0082] Selectable marker transgenics can also be used together with the regulatory elements of the present invention. As used herein, the term "selectable marker transgenic" refers to any transcribable DNA molecule, and its expression in transgenic plants, tissues or cells or its lack thereof can be screened or scored in some way. Selectable marker genes and related selection and screening techniques for the practice of the present invention are known in the art, including but not limited to encoding the following transcribable DNA molecules: beta-glucuronidase (GUS), green fluorescent protein (GFP), proteins that confer antibiotic resistance, and proteins that confer herbicide tolerance. An example of a selectable marker transgenic is provided as SEQ ID NO:17.

[0083] Cell transformation

[0084] The present invention also relates to a method of producing transformed cells and plants comprising one or more regulatory elements operably linked to a transcribable DNA molecule.

[0085] The term "transformation" refers to the introduction of a DNA molecule into a recipient host. As used herein, the term "host" refers to bacteria, fungi or plants, including any cell, tissue, organ or progeny of the bacteria, fungi or plants. Plant tissues and cells of particular interest include protoplasts, callus, roots, tubers, seeds, stems, leaves, seedlings, embryos and pollen.

[0086] As used herein, the term "transformed" refers to a cell, tissue, organ or organism into which an exogenous DNA molecule (such as a construct) has been introduced. The introduced DNA molecule can be integrated into the genomic DNA of the recipient cell, tissue, organ or organism so that the introduced DNA molecule is inherited by subsequent offspring. A "transgenic" or "transformed" cell or organism may also include offspring of the cell or organism and offspring produced by a breeding program that uses such a transgenic organism as a hybrid parent and exhibits a phenotype that is altered by the presence of the exogenous DNA molecule. The introduced DNA molecule may also be introduced transiently into the recipient cell so that the introduced DNA molecule is not inherited by subsequent offspring. The term "transgenic" refers to a bacterium, fungus or plant containing one or more heterologous DNA molecules.

[0087] Many methods for introducing DNA molecules into plant cells are well known to those skilled in the art. The method generally includes selecting a suitable host cell, transforming the host cell with a vector and obtaining the transformed host cell. In the practice of the present invention, the methods and materials for transforming plant cells by introducing plant constructs into the plant genome may include any known and confirmed methods. Suitable methods include, but are not limited to, bacterial infection (e.g., Agrobacterium), binary BAC vectors, direct delivery of DNA (e.g., by PEG-mediated conversion, drying / inhibition-mediated DNA uptake, electroporation, agitation with silicon carbide fibers, and acceleration of DNA-coated particles), gene editing (e.g., CRISPR-Cas systems), etc.

[0088] The host cell can be any cell or organism, such as a plant cell, an algal cell, an algae, a fungal cell, a fungus, a bacterial cell, or an insect cell. In specific embodiments, the host cell and the transformed cell can include cells from a crop plant.

[0089] Transgenic plants can be subsequently regenerated from the transgenic plant cells of the present invention. Seeds can be produced from the transgenic plants using conventional breeding techniques or self-pollination. Such seeds and offspring plants grown from such seeds will contain the recombinant DNA molecules of the present invention and are therefore transgenic.

[0090] Transgenic plants of the present invention can be self-pollinated to provide seeds for homozygous transgenic plants of the present invention (homozygous for recombinant DNA molecules) or hybridized with non-transgenic plants or different transgenic plants to provide seeds for heterozygous transgenic plants of the present invention (heterozygous for recombinant DNA molecules). Such homozygous and heterozygous transgenic plants are referred to as "offspring plants" in this article. Offspring plants are transgenic plants that are passed down from the original transgenic plants and contain recombinant DNA molecules of the present invention. The seeds produced using the transgenic plants of the present invention can be harvested and used to cultivate several generations of transgenic plants, that is, offspring plants of the present invention that contain constructs of the present invention and express genes of concern in agronomy. Descriptions of breeding methods commonly used for different crops can be found in one of several reference books: see, for example, Allard, Principles of Plant Breeding, John Wiley & Sons, NY, U. of CA, Davis, CA, 50-98 (1960); Simmonds, Principles of Crop Improvement, Longman, Inc., NY, 369-399 (1979); Sneep and Hendriksen, Plant breeding Perspectives, Wageningen (Eds.), Center for Agricultural Publishing and Documentation (1979); Fehr, Soybeans: Improvement, Production and Uses, 2nd ed., Monograph, 16:249 (1987); Fehr, Principles of Variety Development, Theory and Technique, (Vol. 1) and Crop Species Soybean (Vol. 2), Iowa State Univ., Macmillan Pub. Co., NY, 360-376 (1987).

[0091] The transformed plants can be analyzed for the presence of one or more target genes and the expression levels and / or profiles conferred by the regulatory elements of the present invention. Those skilled in the art are aware of many methods that can be used to analyze transformed plants. For example, methods for plant analysis include, but are not limited to, Southern or Northern blotting, PCR-based methods, biochemical analysis, phenotypic screening methods, field evaluations, and immunodiagnostic assays. Expression of transcribable DNA molecules can be determined using the methods described by the manufacturer. (Applied Biosystems, Foster City, CA) and were measured using PCR cycling time was determined using the PCR Testing Matrix. Alternatively, the PCR (Third Wave Technologies, Madison, WI) reagents and methods can be used to assess transgene expression.

[0092] The present invention also provides parts of the plants of the present invention. Plant parts include, but are not limited to, leaves, stems, roots, tubers, seeds, endosperms, ovules, and pollen. Plant parts of the present invention may be viable, non-viable, regenerative, and / or non-regenerative. The present invention also includes and provides transformed plant cells comprising the DNA molecules of the present invention. Transformed or transgenic plant cells of the present invention include regenerative and / or non-regenerative plant cells.

[0093] The present invention also provides a commercial product, which is produced by a transgenic plant or part thereof containing the recombinant DNA molecule of the present invention. The commercial product of the present invention comprises a detectable amount of DNA, the DNA comprising a DNA sequence selected from the group consisting of SEQ ID NO: 1-15. As used herein, "commodity product" refers to any composition or product consisting of materials derived from transgenic plants, seeds, plant cells or plant parts containing the recombinant DNA molecules of the present invention. Commercial products include but are not limited to processed seeds, grains, plant parts and meal. The commercial product of the present invention contains a detectable amount of DNA corresponding to the recombinant DNA molecule of the present invention. One or more of the DNA in the test sample can be used to determine the content or source of the commercial product. Any standard detection method for DNA molecules can be used, including the detection method disclosed herein.

[0094] The present invention can be more easily understood by reference to the following examples, which are provided by way of illustration, unless otherwise stated, and are not intended to limit the present invention. It will be appreciated by those skilled in the art that the technology disclosed in the following examples represents the technology that the inventors have found to work well in the practice of the present invention. However, it will be appreciated by those skilled in the art that many changes can be made in the disclosed specific embodiments without departing from the spirit and scope of the present invention, and that the same or similar results are still obtained, therefore, all that is described or shown in the accompanying drawings is interpreted as illustrative and not restrictive.

[0095] Example

[0096] Example 1

[0097] Identification and cloning of regulatory elements

[0098] Novel transcriptional regulatory elements and expression element groups (EXPs) were identified and cloned from the genomic DNA of the dicot species Cucumis melon (WSH-39-1070AN) and Medicago truncatula.

[0099] Transcriptional regulatory elements were selected based on proprietary and public microarray data from transcriptional profiling experiments in soybean (Glycine max) and Arabidopsis thaliana, and homology-based searches using known dicot sequences as queries against proprietary Cucumis melo and proprietary and public Medicago truncatula sequences.

[0100] Use the sequence identified, carry out bioinformatics analysis to identify the regulatory elements in the amplified DNA.For example, carry out bioinformatics analysis to identify the transcription start site (TSS) and any bidirectionality, intron or upstream coding sequence present in the sequence.Use the result of this analysis, limit the regulatory elements in the DNA sequence and primers designed to amplify the regulatory elements.Use the corresponding DNA molecules of each regulatory element of standard polymerase chain reaction condition amplification, wherein the primers contain unique restriction enzyme sites and the genomic DNA isolated from musk melon and Medicago truncatula.Use the standard restriction enzyme digestion and the DNA ligation method of compatible restriction sites, the gained DNA fragment is connected to the basic plant expression vector.

[0101] Analysis of regulatory element TSS and intron / exon splice junctions can be performed using transformed plant tissue. Briefly, plants are transformed with a plant expression vector comprising a cloned DNA fragment operably linked to a heterologous transcribable DNA molecule. Next, regulatory element TSS and intron / exon splice junctions are confirmed by analyzing the DNA sequence of the resulting mRNA transcripts using the 5' RACE system of Rapid Amplification of cDNA Ends, version 2.0 (Invitrogen, Carlsbad, California 9 2008).

[0102] The DNA sequences encoding the transcriptional regulatory expression element set or EXP sequence of Cucumis sativus and Medicago truncatula and their corresponding promoter and leader sequences are shown in Table 1, wherein the DNA sequence consists of a promoter element operably linked to a leader element.

[0103] Table 1. Transcriptional regulatory expression element groups, promoters, leader sequences and introns isolated from Cucumis melo and Medicago truncatula

[0104]

[0105] Example 2

[0106] Analysis of regulatory elements driving GUS expression in stably transformed soybean plants

[0107] Soybean plants are transformed with a vector, particularly a plant expression vector, containing a test regulatory element driving expression of a β-glucuronidase (GUS) transgene. The resulting plants are analyzed for GUS protein expression to assess the effect of the selected regulatory element on expression.

[0108] Soybean plants were transformed with the plant GUS expression constructs listed in Table 2. Regulatory elements were cloned into basic plant expression vectors using standard methods known in the art. The generated plant expression vector contains the right border region from Agrobacterium tumefaciens (B-AGRtu. right border); a first transgenic selection box, which is used to select transformed plant cells that confer resistance to the herbicide glyphosate or the antibiotic spectinomycin; a second transgenic box for evaluating the activity of a regulatory element, which comprises an EXP sequence, the EXP sequence 5' operably linked to the coding sequence of β-glucuronidase (GUS, GOI-Ec.uidA+St.LS1:1:1, SEQ ID NO:17) containing a processable intron derived from the potato light-inducible tissue-specific ST-LS1 gene (Genbank Accession No.: X04753), and 5' operably linked to the 3' terminator region from the E6 gene of Gossypium barbadense (T-Gb.E6-3b:3b:1, SEQ ID NO:18); and a left border region from Agrobacterium tumefaciens (B-AGRtu. left border).

[0109] Table 2. Regulatory elements and corresponding GUS expression plasmid constructs

[0110]

[0111] The above binary transformation vector constructs are used to transform soybean plant cells via Agrobacterium-mediated transformation using methods known in the art. The resulting transformed plant cells are induced to form complete soybean plants.

[0112] The histochemical GUS analysis was used for qualitative and quantitative expression analysis of transformed plants. The whole tissue section was cultivated for an appropriate time with GUS staining solution X-Gluc (5-bromo-4-chloro-3-indolyl-b-glucuronide) (1 mg / ml), rinsed, and visually inspected for blue color. The GUS activity was qualitatively determined by direct visual inspection or by using selected plant organs and tissues to examine under a microscope.

[0113] In order to quantitatively analyze GUS expression, total protein was extracted from the selected tissues of the transformed soybean plants. 1 microgram of total protein was used together with the fluorescent substrate 4-methylumbelliferyl-β-D-glucuronide (MUG), and the total reaction volume was 50 microliters. The reaction product 4-methylumbelliferyl (4-MU) fluoresces to the greatest extent at high pH, ​​wherein the hydroxyl group is ionized. Adding alkaline sodium carbonate solution stopped the assay and adjusted the pH to quantify the fluorescent product. Using the Fluoromax-3 with Micromax reader, fluorescence was measured at 365nm excitation, 445nm emission, wherein the slit width was set to excite 2nm and emit 3nm. Values ​​are provided in units of nmol GUS / hour / mg total protein.

[0114] The following tissues were sampled for GUS expression in: 0 Generation; Vn5 stage sink leaves, source leaves and roots; R1 stage petioles, source leaves, flowers and cotyledons; R3 stage pods and immature seeds; and yellow pod stage embryos and cotyledons. Tables 3 and 4 below show the average quantitative GUS expression of each sampled tissue driven by the regulatory elements shown in Table 2.

[0115] Table 3. Average quantitative GUS expression in stably transformed soybean plants driven by regulatory elements derived from Cucumis melo

[0116]

[0117] Table 4. Average quantitative GUS expression in stably transformed soybean plants driven by regulatory elements derived from Medicago truncatula

[0118]

[0119]

[0120] As can be seen from Tables 3 and 4, each regulatory element has a unique expression pattern in the sampled tissues. EXP-CUCme.Fe2:1 (SEQ ID NO:1) and EXP-CUCme.CipLhcb:1 (SEQ ID NO:4) are both highly expressed in R3 pods and show the lowest expression levels in R3 immature seeds, Vn5 roots, R5 cotyledons, and yellow pod stage embryos and cotyledons. GUS expression driven by EXP-CUCme.Fe2:1 is also high in Vn5 stage sink and source leaves and R1 stage petioles, source leaves, and flowers. The regulatory element EXP-CUCme.Bbz:1 (SEQ ID NO:7) shows the highest expression in Vn5 stage sink and source leaves and R3 stage pods. GUS expression driven by EXP-Mt.Lhcb2:1:1 (SEQ ID NO:10) is highest in Vn5 stage source leaves and R1 petioles. EXP-Mt.PSII-T:1:1 (SEQ ID NO: 13) showed the highest expression in R1 stage source leaves.

[0121] Each regulatory element provides a unique expression pattern that can be used to optimally drive expression of different transgenes, depending on the desired tissue expression preference.

[0122] Example 3

[0123] Enhancer elements derived from regulatory elements

[0124] Enhancers are derived from promoter elements shown in SEQ ID NO: 2, 5, 8, 11 and 14. Enhancer elements may include one or more cis-regulatory elements that, when operably linked to the promoter element 5' or 3', or to other enhancer elements 5' or 3' operably linked to the promoter, can increase or regulate the expression level of a transcribable DNA molecule, or provide for the expression of a transcribable DNA molecule in a specific cell type or plant organ, or at a specific time point in development or circadian rhythm. Enhancers are made by removing the TATA box or a functionally similar element and any downstream sequence from a promoter that allows transcription to be initiated from a promoter sequence, such as a sequence shown in SEQ ID NO: 2, 5, 8, 11 and 14, or a fragment thereof.

[0125] The TATA box in plant promoters is not as highly conserved as in some other eukaryotic organisms. Therefore, in order to define a segment as an enhancer, the transcription start site (TSS) of the gene must first be identified, where the 5'UTR is transcribed first. For example, the transcriptional regulatory element EXP-Mt.Lhcb2:1:1 (SEQ ID NO:10) is composed of a promoter element P-Mt.Lhcb2-1:2:1 (SEQ ID NO:11) operably linked to a 5'UTR or leader element L-Mt.Lhcb2-1:2:1 (SEQ ID NO:12). Within the 1837 bp promoter element P-Mt.Lhcb2-1:2:1 (SEQ ID NO:11), a putative core TATA-like element is found within nucleotides 1798 to 1803. The enhancer fragment derived from P-Mt.Lhcb2-1:2:1 may comprise nucleotides 1 to 1797 of SEQ ID NO:11, resulting in a sequence as shown in SEQ ID NO:16 (E-Mt.Lhcb2). The enhancer derived from the promoter P-Mt.Lhcb2-1:2:1 (SEQ ID NO:11) may further comprise a smaller fragment of E-Mt.Lhcb2 (SEQ ID NO:16). The effectiveness of the enhancer element derived from the promoter P-Mt.Lhcb2-1:2:1 (SEQ ID NO:11) is empirically determined by constructing a chimeric transcriptional regulatory element comprising the enhancer derived from the promoter P-Mt.Lhcb2-1:2:1 (SEQ ID NO:11) operably linked to the promoter and leader sequence and used to drive expression of a transcribable DNA molecule such as GUS in a stable or transient plant assay.

[0126] Further refinement of the enhancer element may be required and empirical verification. In addition, the position of the enhancer element relative to other elements within the chimeric transcriptional regulatory element is also determined empirically, because the order of each element within the chimeric transcriptional regulatory element can impart different effects, depending on the relative position of each element. Some promoter elements will have multiple TATA boxes or TATA box-like elements and may have multiple transcription start sites. In these cases, it may be necessary to first determine the location of the first TSS and then begin to design the enhancer using the first TSS to prevent potential initiation of transcription from occurring within the putative enhancer element.

[0127] Enhancer elements derived from promoter elements shown in SEQ ID NOs: 2, 5, 8, 11, and 14 are cloned using methods known in the art so as to be operably linked to the promoter element 5' or 3', or to another enhancer element 5' or 3' that is operably linked to the promoter. Alternatively, enhancer elements can be cloned using methods known in the art to provide larger enhancer elements, which are composed of two or more enhancer copies and cloned using methods known in the art so as to be operably linked to the promoter element 5' or 3', or to another enhancer element 5' or 3', which is in turn operably linked to the promoter to produce a chimeric transcriptional regulatory element. Enhancer elements can also be cloned using methods known in the art so that the enhancer element is operably linked to a promoter element 5' derived from an organism of a different genus, or to another enhancer element 5' or 3' derived from an organism of another genus, which is operably linked to a promoter derived from an organism of the same or different genus, to produce a chimeric transcriptional regulatory element. GUS expression plant transformation vectors can be constructed using methods known in the art, similar to the constructs described in Example 2 above, wherein the resulting plant expression vector contains: the right border region from Agrobacterium tumefaciens (B-AGRtu. right border); a first transgenic selection cassette for selecting transformed plant cells that confer resistance to the antibiotic, spectinomycin; and a second transgenic cassette for testing an enhancer element, the enhancer element being composed of an enhancer element operably linked 5' or 3' to a promoter element or 5' or 3' to an additional enhancer element, the additional enhancer element in turn being operably linked to a promoter, the promoter being operably linked 5' to a leader element, the leader element being linked to β-glucuronidase (GUS, GOI-Ec.uidA+St.LS1:1:1, SEQ ID NO:17) is operably linked to a coding sequence containing a processable intron from a potato light-induced tissue-specific ST-LS1 gene (Genbank accession number: X04753), which is operably linked to a 3' terminator region from the E6 gene of Gossypium barbadense (T-Gb.E6-3b:3b:1, SEQ ID NO:18); and a left border region from Agrobacterium tumefaciens (B-AGRtu.left border). The resulting plasmid is used to transform soybean plants or other genus plants by the above method. Alternatively, protoplast cells derived from soybean or other genus plants are transformed using methods known in the art for transient assays.

[0128] GUS expression driven by a regulatory element comprising one or more enhancers is evaluated in a stable or transient plant assay to determine the effect of the enhancer element on the expression of a transcribable DNA molecule. Modification of one or more enhancer elements or duplication of one or more enhancer elements can be performed based on empirical experiments and the resulting gene expression regulation observed using each regulatory element combination. Changing the relative position of one or more enhancers in the resulting regulatory or chimeric regulatory element can affect the transcriptional activity or specificity of the regulatory or chimeric regulatory element and is determined empirically to identify the optimal enhancer for the desired transgenic expression profile in corn plants or other genera of plants.

[0129] *******

[0130] Having illustrated and described the principles of the invention, it will be apparent to those skilled in the art that modifications may be made to the invention in arrangement and detail without departing from these principles. We claim protection for all modifications within the spirit and scope of the claims. All publications and open patent documents cited herein are hereby incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference herein.

Claims

1. A recombinant DNA molecule comprising a DNA sequence of SEQ ID NO: 4 or 5, wherein the sequence is operably linked to a heterologous transcribable DNA molecule.

2. The recombinant DNA molecule of claim 1, wherein the DNA sequence comprises gene regulatory activity.

3. The recombinant DNA molecule of claim 1, wherein the heterologous transcribable DNA molecule comprises a gene of agronomic interest.

4. The recombinant DNA molecule of claim 3, wherein the gene of agronomic interest confers herbicide tolerance to a plant.

5. The recombinant DNA molecule of claim 3, wherein the gene of agronomic interest confers resistance to plant pests.

6. A transgenic plant cell comprising the recombinant DNA molecule of claim 1, wherein the transgenic plant cell is non-regenerable.

7. The transgenic plant cell of claim 6, wherein the transgenic plant cell is a monocotyledonous plant cell.

8. The transgenic plant cell of claim 6, wherein the transgenic plant cell is a dicotyledonous plant cell.

9. A method for producing a commodity product, the method comprising obtaining a transgenic plant or a part thereof comprising the recombinant DNA molecule of claim 1, and thereby producing the commodity product.

10. The method of claim 9, wherein the commodity product is selected from the group consisting of protein concentrates, protein isolates, grains, starches, seeds, meals, flours, biomass, and seed oils.

11. A method for expressing a transcribable DNA molecule, the method comprising obtaining a transgenic plant comprising the recombinant DNA molecule of claim 1 and culturing the plant, wherein the transcribable DNA is expressed.

Citation Information

Patent Citations

  • Recombinant DNA constructs and methods for controlling gene expression

    US20060200878A1

  • Phased small RNAs

    US20080066206A1

  • Anti-sense regulation of gene expression in plant cells

    US5107065A

  • Approaches useful for the control of root nodulation of leguminous plants

    US5229114A

  • Control of fruit ripening and senescence in plants

    US5512466A